Directorate General Health Services Tender
If you're typing tender ID over and again or finding it difficult to go through the cumbersome government websites for looking at Delhi tenders online. We have come up with a solution i.e. we have collated every eprocurement Delhi tender on BidAssist. Also, for any queries related to an e-tender Delhi, like the bidding process, registration process, etc., the same are explained below.
Directorate General Health Services Tender
Healthcare and Medicine
Eprocure
Opening Date12 Dec 2024
Closing Date9 Jan 2025
Tender AmountRefer Documents
Costs
EMD
₹ 8,50,000Document Cost
Refer DocumentsTender Fee
Refer Documents
Summary
Tender For Supply Of Quadrivalent And Trivalent Seasonal Influenza Vaccine(siv)
Description
Scription for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user
Contact
Tender Id
2024_DGHS_839168_1Tender No
PS/2/SIV/Haj Session 2025/2024-25/06Tender Authority
Directorate General Health Services ViewPurchaser Address
-Website
http://https://dghs.gov.in/
GEM & Bid Advisory Services
Get portal registration, tender bidding, product/service listing or vendor/MSME certification services at a nominal cost
Documents
BOQ Items
... More
Seasonal Influenza Vaccine (Trivalent)
(For Adults)
Specification: As per the WHO recommendations the Trrivalent vaccines for use in the 2025 influenza season (NH) contain the following: Egg-based Vaccines
• an A/Victoria/4897/2022 (H1N1)pdm09-like virus;
• an A/Thailand/8/2022 (H3N2)-like virus;
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery.
Minimum Shelf Life: 12 Months
1
-
-
... More
Seasonal Influenza Vaccine (Trivalent)
(For Adults)
Specification: As per the WHO recommendations the Trivalent vaccines for use in the 2025 influenza season (NH) contain the following: Egg-based Vaccines
• an A/Victoria/4897/2022 (H1N1)pdm09-like virus;
• an A/Thailand/8/2022 (H3N2)-like virus;
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery.
Minimum Shelf Life: 12 Months
10
-
-
... More
Seasonal Influenza Vaccine (Trivalent)
(For Adults)
Specification: As per the WHO recommendations the Trivalent vaccines for use in the 2025 influenza season (NH) contain the following: Egg-based Vaccines
• an A/Victoria/4897/2022 (H1N1)pdm09-like virus;
• an A/Thailand/8/2022 (H3N2)-like virus;
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery.
Minimum Shelf Life: 12 Months
1
-
-
... More
Seasonal Influenza Vaccine (Quadrivalent)
(For Adults)
Specification: As per the WHO recommendations the quadrivalent vaccines for use in the 2025 influenza season (NH) contain the following: Cell- or recombinant-based Vaccines
• an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
• an A/Massachusetts/18/2022 (H3N2)-like virus;
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
• a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus. Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery.
Minimum Shelf Life: 12 Months
1
-
-
... More
Seasonal Influenza Vaccine (Quadrivalent)
(For Adults)
Specification: As per the WHO recommendations the quadrivalent vaccines for use in the 2025 influenza season (NH) contain the following: Cell- or recombinant-based Vaccines
• an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
• an A/Massachusetts/18/2022 (H3N2)-like virus;
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
• a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus. Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery.
Minimum Shelf Life: 12 Months
10
-
-
... More
Seasonal Influenza Vaccine (Quadrivalent)
(For Adults)
Specification: As per the WHO recommendations the quadrivalent vaccines for use in the 2025 influenza season (NH) contain the following: Cell- or recombinant-based Vaccines
• an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
• an A/Massachusetts/18/2022 (H3N2)-like virus;
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
• a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus. Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery.
Minimum Shelf Life: 12 Months
1
-
-
... More
Seasonal Influenza Vaccine (Trivalent)
(For Adults)
Specification: As per the WHO recommendations the Trivalent vaccines for use in the 2025 influenza season (NH) contain the following: Cell- or recombinant-based Vaccines
• an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
• an A/Massachusetts/18/2022 (H3N2)-like virus;
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery.
Minimum Shelf Life: 12 Months
1
-
-
... More
Seasonal Influenza Vaccine (Trivalent)
(For Adults)
Specification: As per the WHO recommendations the Trrivalent vaccines for use in the 2025 influenza season (NH) contain the following: Cell- or recombinant-based Vaccines
• an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
• an A/Massachusetts/18/2022 (H3N2)-like virus;
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery.
Minimum Shelf Life: 12 Months
10
-
-
... More
Seasonal Influenza Vaccine (Trivalent)
(For Adults)
Specification: As per the WHO recommendations the Trrivalent vaccines for use in the 2025 influenza season (NH) contain the following: Cell- or recombinant-based Vaccines
• an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
• an A/Massachusetts/18/2022 (H3N2)-like virus;
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery.
Minimum Shelf Life: 12 Months
1
-
-
Evaluation Notes How It Works ?
Potential Partner
Select Your Requirements
Past BiddersThis list is curated from the bidders of the similar tenders in the past
- Bidder NameThis Information is for unsubscribed user This Information is for unsubscribed user
- Awarded Ratexx%
- Bidder NameThis Information is for unsubscribed user This Information is for unsubscribed user
- Awarded Ratexx%
- Bidder NameThis Information is for unsubscribed user This Information is for unsubscribed user
- Awarded Ratexx%